GGrantIndex
Sort

78,016 grants matching breast cancer

NCTN Deep South Research Consortium

$482,879
Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2019 · CA

Research Project

$482,863
Gloria D Coronado · Fred Hutchinson Cancer Research Center · U54 · FY2010 · CA

RNA EXO-Codes: A novel way to reprogram pathological exosomes

$482,859
Juliane Nguyen · Univ Of North Carolina Chapel Hill · R01 · FY2019 · EB

Correlative Studies of erbB-2/HER2 and p53 in CALGB Pro.

$482,857
University Of Michigan At Ann Arbor · R01 · FY2003 · CA

Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors

$482,812
Laura Q Rogers · University Of Alabama At Birmingham · R01 · FY2025 · CA

Conserved Biology of Tumor and Microenvironment in Breast Cancer Progression

$482,800
Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2008 · CA

Epidemiologic Field Studies

$482,775
Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

Improving breast ultrasound specificity through SFRP2 targeted molecular imaging

$482,737
Paul A Dayton · Univ Of North Carolina Chapel Hill · U01 · FY2017 · CA

MEASUREMENT ERRORS IN CANCER EPIDEMIOLOGY

$482,709
Brigham And Women'S Hospital · R01 · FY2002 · CA

Academic-Industrial Partnership for Translation of Acoustic Angiography

$482,698
Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA

Project 1: Synthesis, Characterization and Biomonitoring of DNA Containing Site-Specific Chemotherapy-Induced Complex Alkylation Products

$482,673
Carmelo J Rizzo · Vanderbilt University · P01 · FY2018 · CA

CANCER IN THE JERUSALEM PERINATAL STUDY COHORT

$482,662
New York University School Of Medicine · R01 · FY2002 · CA

Therapeutic targeting of autophagy-dependent cancer

$482,625
Andrew M Thorburn · University Of Colorado Denver · R01 · FY2016 · CA

The role of TRIM37 in driving tumorigenesis and cancer-specific vulnerability to PLK4 inhibition

$482,599
Sergi Regot · Johns Hopkins University · R01 · FY2024 · CA

Atlanta Regional Community Clinical Oncology Program (ARCCOP)

$482,599
Thomas E Seay · St. Joseph'S Hospital · U10 · FY2011 · CA

NCTN Deep South Research Consortium

$482,539
Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2023 · CA

Breast Cancer Treatment with Antibody Targeted T Cells

$482,535
Lawrence G Lum · Roger Williams Hospital · R01 · FY2006 · CA

PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM - A NOVEL MULTI-ANTIGEN VACCINE (TNBCVAX) TO PREVENT TRIPLE NEGATIVE BREAST CANCER

$482,513
Chinthalapally Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2021 · CA

Risk prediction methods

$482,480
Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA

MARKERS FOR RISK ASSESSMENT/EARLY DETECTION OF LUNG AND

$482,456
University Of Texas Sw Med Ctr/Dallas · U01 · FY2003 · CA

Discrete Frequency Infrared Spectroscopic Imaging for Breast Histopathology

$482,453
Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2014 · EB

NEXT GENERATION APPROACHES TO BREAST CANCER USING IMAGE GUIDED DRUG DELIVERY

$482,398
Gregory M Lanza · Washington University · R01 · FY2015 · CA

Research and Treatment in Comparative Effectiveness, QI and IND Research

$482,388
Ruth R Faden · Johns Hopkins University · RC1 · FY2010 · RR

IBCSG STATISTICAL CENTER--A BREAST CANCER STUDY RESOURCE

$482,375
Richard D Gelber · Dana-Farber Cancer Inst · U24 · FY2010 · CA

Regulation of metastatic progression by an endothelial-derived factor

$482,370
Sohail F. Tavazoie · Rockefeller University · R01 · FY2019 · CA